Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Winer

Showing results (21-30 of 465) with videos related to

Pageof 47
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Optimal use of aromatase inhibitors: to lead or to follow?Nancy U Lin, Eric P Winer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Clinical differences among the aromatase inhibitorsJennifer A Ligibel, Eric P Winer
JAMA|July 16, 2002
Informing clinical trial participants about study resultsAnn H Partridge, Eric P Winer
JAMA|January 23, 2019
Breast Cancer TreatmentAdrienne G Waks, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Refining therapy for human epidermal growth factor receptor 2-positive breast cancer: T stands for trastuzumab, tumor size, and treatment strategyHarold J Burstein, Eric P Winer
Journal of the National Cancer Institute|December 14, 2017
Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is UnderwayPhilip D Poorvu, Eric P Winer
Lancet (London, England)|February 18, 2014
Defining success in neoadjuvant breast cancer trialsLisa A Carey, Eric P Winer
Seminars in Oncology|July 26, 2002
Trastuzumab/chemotherapy combinations in metastatic breast cancerJennifer A Ligibel, Eric P Winer
Oncology|May 22, 2003
Hormonal therapy in postmenopausal women with breast cancerSusana M Campos, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2019
Reply to A.K. Goel et alSara M Tolaney, Eric P Winer
Pageof 47

Showing results (21-30 of 465) with videos related to

Sort By:
Pageof 47
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Optimal use of aromatase inhibitors: to lead or to follow?Nancy U Lin, Eric P Winer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Clinical differences among the aromatase inhibitorsJennifer A Ligibel, Eric P Winer
JAMA|July 16, 2002
Informing clinical trial participants about study resultsAnn H Partridge, Eric P Winer
JAMA|January 23, 2019
Breast Cancer TreatmentAdrienne G Waks, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Refining therapy for human epidermal growth factor receptor 2-positive breast cancer: T stands for trastuzumab, tumor size, and treatment strategyHarold J Burstein, Eric P Winer
Journal of the National Cancer Institute|December 14, 2017
Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is UnderwayPhilip D Poorvu, Eric P Winer
Lancet (London, England)|February 18, 2014
Defining success in neoadjuvant breast cancer trialsLisa A Carey, Eric P Winer
Seminars in Oncology|July 26, 2002
Trastuzumab/chemotherapy combinations in metastatic breast cancerJennifer A Ligibel, Eric P Winer
Oncology|May 22, 2003
Hormonal therapy in postmenopausal women with breast cancerSusana M Campos, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2019
Reply to A.K. Goel et alSara M Tolaney, Eric P Winer
Pageof 47